Effective governance of access and benefit-sharing under the Convention on Biological Diversity

Biodiversity and Conservation

Volumn 20, Issue 10, 2011, Pages 2243-2261

  Richerzhagen, Carmen ^a  

^a GERMAN DEVELOPMENT INSTITUTE   (Germany)

Author keywords

Access and benefit sharing (ABS); Biodiversity protection; Convention on Biological Diversity; Institutional economics; Regime effectiveness

Indexed keywords

BIODIVERSITY; COMMERCIAL ACTIVITY; COMMERCIALIZATION; CONSERVATION MANAGEMENT; ENVIRONMENTAL DEGRADATION; ENVIRONMENTAL ECONOMICS; ENVIRONMENTAL IMPACT ASSESSMENT; GOVERNANCE APPROACH; INCENTIVE; INSTITUTIONAL FRAMEWORK; INTERNATIONAL AGREEMENT; PUBLIC ACCESS;

EID: 79960975002     PISSN: 09603115     EISSN: 15729710     Source Type: Journal    
DOI: 10.1007/s10531-011-0086-0     Document Type: Article

References (59)

1. Alchian AA (2007) Property rights (online). Liberty Fund, Inc. http://www. econlib. org/LIBRARY/Enc/PropertyRights. html. Accessed 21 April 2007.
2. Anuradha RV (2001) IPRs: implications for biodiversity and local and indigenous communities. Rev Eur Commun Int Environ Law 10: 27-36.
3. Artuso A (2002) Bioprospecting, benefit sharing, and biotechnological capacity building. World Dev 30: 1355-1368.
4. Barber CV, Johnston S, Tobin B (2003) User measures options for developing measures in user countries to implement the access and benefit-sharing provisions of the Convention on Biological Diversity. United Nations University, Tokyo.
5. Barrett CB, Lybbert TL (2000) Is bioprospecting a viable strategy for conserving tropical ecosystems? Ecol Econ 34: 293-300.
6. Barzel Y (1997) Economic analysis of property rights. Cambridge University Press, Cambridge.
7. Baumol WJ, Blinder AS (1994) Economics: principles and policy. Dryden Press, Orlando.
8. Boisvert V, Caron A (2002) The Convention on Biological Diversity: an institutionalist perspective of the debates. J Econ Issues 36: 151-166.
9. Boisvert V, Vivien F-D (2005) The Convention on Biological Diversity: a conventionalist approach. Ecol Econ 53: 461-472.
10. Braga CAP (1996) Trade-related intellectual property issues: the Uruguay-round agreement and its economic implications. In: Martin W, Winter LA (eds) The Uruguay round and developing countries. Cambridge University Press, Cambridge.
11. Brunnengraeber A, Dietz K, Hirschl B, Walk H (2006) Interdisciplinarity in governance research. GARNET Working Paper 08/2006.
12. CBD (Convention on Biological Diversity) (1992) The Convention on Biological Diversity.
13. CBD (Convention on Biological Diversity) (2011a) Competent national authorities on access and benefit sharing (ABS CNA) (online). http://www. cbd. int/doc/lists/nfp-abs-cna. pdf. Accessed 11 May 2011.
14. CBD (Convention on Biological Diversity) (2011b) Database on ABS measures (online). http://www. cbd. int/programmes/socio-eco/benefit/measures. aspx. Accessed 26 April 2011.
15. Chen Y, Puttitanun T (2005) Intellectual property rights and innovation in developing countries. J Dev Econ 78: 474-493.
16. Coase RH (1960) The problem of social cost. J Law Econ 3: 1-44.
17. Columbia University (1999) Access to genetic resources. An evaluation of the development and implementation of recent regulation and access agreements. Columbia University, School of International and Public Affairs, New York.
18. Dahlmann CJ (1979) The problem of externality. J Law Econ 21(2): 141-162.
19. Dávalos LM, Sears RR, Raygorodetsky G, Simmons BL, Cross H, Grant T, Barnes T, Putzel L, Porzecanski AL (2003) Regulating access to genetic resources under the Convention on Biological Diversity: an analysis of selected case studies. Biodivers Conserv 12: 1511-1524.
20. Day-Rubenstein K, Frisvold GB (2001) Genetic prospecting and biodiversity development agreements. Land Use Policy 18: 205-219.
21. Dedeurwaerdere T (2005) From bioprospecting to reflexive governance. Ecol Econ 53: 473-491.
22. Dedeurwaerdere T (2010) Global microbial commons: institutional challenges for the global exchange and distribution of microorganisms in the life sciences. Res Microbiol 161: 414-421.
23. Dedeurwaerdere T, Louaf S, Richerzhagen C, Tobin B (2005) Roundtable on practicality, feasibility and cost of certificates of origin. 2nd Paris roundtable on ABS governance. IDDRI-UNU/IAS-CPDR, Paris.
24. EU Commission (2003) Communication from the Commission to the European Parliament and the Council, the implementation by the EC of the "bonn guidelines" on access to genetic resources and benefit-sharing under the Convention on Biological Diversity, COM (2003) 821 final, Brussels, 23. 12. 2003.
25. Fritsch M, Wein T, Ewers H-J (2003) Marktversagen und Wirtschaftspolitik. Franz Vahlen, München.
26. Gehl Sampath P (2005) Regulating bioprospecting: institutions for drug research, access and benefit-sharing. United Nations University Press, Tokyo.
27. Gould DM, Gruben WC (1996) The role of intellectual property rights in economic growth. J Dev Econ 48(2): 323-350.
28. Holm-Mueller K, Richerzhagen C, Taeuber S (2005) Users of genetic resources in Germany awareness, participation and positions regarding the Convention on Biological Diversity. Bundesamt fuer Naturschutz, Bonn.
29. Kanowski P, Sinclair D, Freeman B (1999) International approaches to forest management certification and labelling of forest products: a review. Agriculture, Fisheries and Forestry-Australia, Canberra, ACT, October 1999.
30. Kaufmann D, Kraay A, Mastruzzi M (2006) Governance matters V: governance indicators for 1996-2005. The World Bank.
31. Laird SA, Wynberg R (2002) Institutional policies for biodiversity research. In: Laird SA (ed) Biodiversity and traditional knowledge. Equitable partnerships in practice. Earthscan, London.
32. Lerch A (1998) Property rights and biodiversity. Eur J Law Econ 6: 285-304.
33. MEA (Millennium Ecosystem Assessment) (2005) Ecosystems and human well-being-biodiversity synthesis. MEA, Washington, DC.
34. Moran K (2000) Bioprospecting: lessons from benefit-sharing experiences. Int J Biotechnol 2: 132-144.
35. Mulholland DM, Wilman EA (2003) Bioprospecting and biodiversity contracts. Environ Dev Econ 8: 417-435.
36. Nagoya Protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization to the Convention on Biological Diversity (2010).
37. Nijar GS (2011) The Nagoya Protocol on access and benefit sharing of genetic resources an analysis. Ceblaw brief. Kuala Lumpur.
38. North DC (1990) Institutions, institutional change and economic performance (political economy of institutions and decisions). Cambridge University Press, Cambridge.
39. OECD (Organisation for Economic Cooperation and Development) (2003a) Economic issues in access and benefit sharing of genetic resources: a framework for analysis. OECD, Paris.
40. OECD (Organisation for Economic Cooperation and Development) (2003b) Harnessing markets for biodiversity. Towards conservation and sustainable use. OECD Publishing, Paris.
41. Rausser GC, Small AA (2000) Valuing research leads: bioprospecting and the conservation of genetic resources. J Political Econ 108: 173-206.
42. Reid WV, Laird AS, Gámez R, Sittenfeld A, Janzen DH, Gollin MA, Juma C (1993) A new lease on life. In: Reid WV, Laird AS, Gámez R, Sittenfeld A, Janzen DH, Gollin MA, Juma C (eds) Biodiversity prospecting: using genetic resources for sustainable development. World Resource Institute, Washington, DC.
43. Reji KJ (2010) International regime on access and benefit sharing: where are we now? Asian Biotechnol Dev Rev 12: 77-94.
44. Richerzhagen C (2010) Protecting biological diversity-the effectiveness of access and benefit-sharing regimes. Routledge, New York.
45. Richter R, Furubotn E (1996) Neue Institutionenökonomik. Mohr, Tübingen.
46. Rosenthal JP (1996) The International Cooperative Biodiversity Groups (ICBG) program. A benefit-sharing case study for the conference of the parties to Convention on Biological Diversity.
47. SCBD (Secretariat of the Convention on Biodiversity) (2008) Access and benefit-sharing in practice: trends in partnerships across sectors. CBD, Montreal.
48. Sedjo RA (1992) Property rights, genetic resources, and biotechnological change. J Law Econ 35: 199-213.
49. Simpson RD, Craft AB (1996) The social value of using biodiversity in new pharmaceutical product research. Resources for the Future, Washington, DC.
50. Simpson RD, Sedjo RA, Reid JW (1996) Valuing biodiversity for use in pharmaceutical research. J Political Econ 104: 163-185.
51. Swanson TM (1995) Why does biodiversity decline? The analysis of forces for global change. In: Swanson TM (ed) Economics and ecology of biodiversity decline: the forces driving global change. Cambridge University Press, Cambridge.
52. Swanson TM, Goeschl T (2000) Property rights issues involving plant genetic resources: implications of ownership for economic efficiency. Ecol Econ 32: 75-92.
53. TEEB (The Economics of Ecosystems and Biodiversity for National and International Policy Makers) (2009a) Chapter 5 Rewarding benefits through payments and markets.
54. TEEB (The Economics of Ecosystems and Biodiversity for National and International Policy Makers) (2009b) Summary: responding to the value of nature.
55. ten Kate K, Laird SA (1999) The commercial use of biodiversity-access to genetic resources and benefit-sharing. Earthscan, London.
56. Vogel JH (2000) The biodiversity cartel: transforming traditional knowledge into trade secrets. CARE, Quito.
57. Williamson OE (1983) Credible commitments: using hostages to support exchange. Am Econ Rev 73: 519-540.
58. Williamson OE (1985) The economic institutions of capitalism: firms, markets, relational contracting. Free Press, New York.
59. Williamson OE (1991) Comparative economic organization: the analysis of discrete structural alternatives. Adm Sci Q 36: 269-296.